Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9430689rdf:typepubmed:Citationlld:pubmed
pubmed-article:9430689lifeskim:mentionsumls-concept:C0043393lld:lifeskim
pubmed-article:9430689lifeskim:mentionsumls-concept:C0010222lld:lifeskim
pubmed-article:9430689lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:9430689lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:9430689lifeskim:mentionsumls-concept:C1414254lld:lifeskim
pubmed-article:9430689lifeskim:mentionsumls-concept:C1823197lld:lifeskim
pubmed-article:9430689lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:9430689lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:9430689lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:9430689lifeskim:mentionsumls-concept:C1154588lld:lifeskim
pubmed-article:9430689lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:9430689lifeskim:mentionsumls-concept:C0066772lld:lifeskim
pubmed-article:9430689pubmed:issue3lld:pubmed
pubmed-article:9430689pubmed:dateCreated1998-2-12lld:pubmed
pubmed-article:9430689pubmed:abstractTextWe have functionally expressed the human cDNA encoding the putative lysophosphatidic acid (LPA) receptor Edg-2 (Vzg-1) in Saccharomyces cerevisiae in an attempt to determine the agonist specificity of this G-protein-coupled receptor. LPA activated the pheromone response pathway in S. cerevisiae expressing Edg-2 in a time- and dose-dependent manner as determined by induction of a pheromone-responsive FUS1::lacZ reporter gene. LPA-mediated activation of the pheromone response pathway was dependent on mutational inactivation of the SST2 gene, the GTPase-activating protein for the yeast G alpha protein (the GPA1 gene product). This indicates that, in sst2 delta yeast cells, Edg-2 can efficiently couple to the yeast heterotrimeric G-protein in response to LPA and activate the yeast mitogen-activated protein kinase pathway. The Edg-2 receptor showed a high degree of specificity for LPA; other lyso-glycerophospholipids, sphingosine 1-phosphate, and diacyl-glycerophospholipids did not activate FUS1::lacZ. LPA analogs including a cyclic phosphoester form and ether-linked forms of LPA activated FUS1::lacZ, although fatty acid chains of 6 and 10 carbons did not activate FUS1::lacZ, suggesting a role for the side chain in ligand binding or receptor activation. These results indicate that Edg-2 encodes a highly specific LPA receptor.lld:pubmed
pubmed-article:9430689pubmed:languageenglld:pubmed
pubmed-article:9430689pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9430689pubmed:citationSubsetIMlld:pubmed
pubmed-article:9430689pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9430689pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9430689pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9430689pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9430689pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9430689pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9430689pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9430689pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9430689pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9430689pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9430689pubmed:statusMEDLINElld:pubmed
pubmed-article:9430689pubmed:monthJanlld:pubmed
pubmed-article:9430689pubmed:issn0021-9258lld:pubmed
pubmed-article:9430689pubmed:authorpubmed-author:TomeiL DLDlld:pubmed
pubmed-article:9430689pubmed:authorpubmed-author:KawanishiKKlld:pubmed
pubmed-article:9430689pubmed:authorpubmed-author:GoddardJ GJGlld:pubmed
pubmed-article:9430689pubmed:authorpubmed-author:WuJ JJJlld:pubmed
pubmed-article:9430689pubmed:authorpubmed-author:EricksonJ RJRlld:pubmed
pubmed-article:9430689pubmed:authorpubmed-author:KieferM CMClld:pubmed
pubmed-article:9430689pubmed:authorpubmed-author:TigyiGGlld:pubmed
pubmed-article:9430689pubmed:issnTypePrintlld:pubmed
pubmed-article:9430689pubmed:day16lld:pubmed
pubmed-article:9430689pubmed:volume273lld:pubmed
pubmed-article:9430689pubmed:ownerNLMlld:pubmed
pubmed-article:9430689pubmed:authorsCompleteYlld:pubmed
pubmed-article:9430689pubmed:pagination1506-10lld:pubmed
pubmed-article:9430689pubmed:dateRevised2008-10-23lld:pubmed
pubmed-article:9430689pubmed:meshHeadingpubmed-meshheading:9430689-...lld:pubmed
pubmed-article:9430689pubmed:meshHeadingpubmed-meshheading:9430689-...lld:pubmed
pubmed-article:9430689pubmed:meshHeadingpubmed-meshheading:9430689-...lld:pubmed
pubmed-article:9430689pubmed:meshHeadingpubmed-meshheading:9430689-...lld:pubmed
pubmed-article:9430689pubmed:meshHeadingpubmed-meshheading:9430689-...lld:pubmed
pubmed-article:9430689pubmed:meshHeadingpubmed-meshheading:9430689-...lld:pubmed
pubmed-article:9430689pubmed:meshHeadingpubmed-meshheading:9430689-...lld:pubmed
pubmed-article:9430689pubmed:meshHeadingpubmed-meshheading:9430689-...lld:pubmed
pubmed-article:9430689pubmed:meshHeadingpubmed-meshheading:9430689-...lld:pubmed
pubmed-article:9430689pubmed:meshHeadingpubmed-meshheading:9430689-...lld:pubmed
pubmed-article:9430689pubmed:meshHeadingpubmed-meshheading:9430689-...lld:pubmed
pubmed-article:9430689pubmed:meshHeadingpubmed-meshheading:9430689-...lld:pubmed
pubmed-article:9430689pubmed:meshHeadingpubmed-meshheading:9430689-...lld:pubmed
pubmed-article:9430689pubmed:meshHeadingpubmed-meshheading:9430689-...lld:pubmed
pubmed-article:9430689pubmed:meshHeadingpubmed-meshheading:9430689-...lld:pubmed
pubmed-article:9430689pubmed:year1998lld:pubmed
pubmed-article:9430689pubmed:articleTitleEdg-2/Vzg-1 couples to the yeast pheromone response pathway selectively in response to lysophosphatidic acid.lld:pubmed
pubmed-article:9430689pubmed:affiliationLXR Biotechnology Inc., Richmond, California 94804, USA. jerickson@lxr.comlld:pubmed
pubmed-article:9430689pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9430689lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9430689lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9430689lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9430689lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9430689lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9430689lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9430689lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9430689lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9430689lld:pubmed